Proprietary microbial strains can represent a major strategic asset for companies working in industrial fermentation, probiotics, food biotechnology, environmental applications or animal health. Their value may come from years of screening, selection, optimisation, process adaptation or accumulated know-how.
Genomics can help companies better document, monitor and protect these strains. By characterising the genome of a proprietary strain, it becomes possible to establish a genomic identity, identify specific markers, monitor stability and support traceability over time.
A proprietary strain is valuable only if it can be clearly identified, differentiated and monitored. Traditional identification methods may confirm a species or genus, but they are often insufficient to distinguish closely related strains or to document unique genomic features.
Genome sequencing provides a much more detailed description of the strain. It can support internal documentation, R&D decisions, quality control, collaboration with partners and long-term strain management.
The first step in protecting a proprietary microbial strain is often to generate a high-quality genomic reference. This reference genome can be used to define the genetic identity of the strain and to compare future isolates against the original material.
Depending on the project, this reference may include genome assembly, genome annotation, ANI calculation, SNP profiles, pangenome position, plasmid description and identification of specific genomic regions.
Comparative genomics can help identify markers that distinguish a proprietary strain from related public genomes, competitors' strains or internal strain collections. These markers may correspond to SNPs, specific genes, accessory genome regions or structural genomic features.
Once identified, these markers can be used for strain authentication, PCR or qPCR assay design, routine monitoring and traceability studies.
Protecting a strain also means ensuring that it remains stable over time. During storage, propagation, scale-up or production, microbial strains may accumulate mutations, lose plasmids or undergo genomic rearrangements.
Comparing production isolates with the original reference genome can help detect genetic drift, SNP accumulation, gene loss, plasmid variation or other genomic changes that may affect strain value or industrial performance.
Genomics can support traceability by determining whether an isolate corresponds to the proprietary strain, a derivative variant, a related organism or an external contaminant. This can be important during production monitoring, contamination investigation, technology transfer or collaboration with partners.
SNP analysis, pangenome analysis, ANI and marker-based detection can all contribute to a robust genomic traceability strategy.
Genomic data can support the documentation of microbial resources and may contribute to discussions around intellectual property, know-how protection, strain differentiation and internal traceability. It can help establish what makes a strain unique and how it differs from related strains.
However, genomic characterisation is not a substitute for legal advice. Decisions related to patents, deposits, contracts or intellectual property protection should be discussed with qualified legal professionals. Genomics provides scientific evidence that can support such strategies.
A practical strategy often combines whole-genome sequencing and targeted molecular tools. Comparative genomics can first identify strain-specific markers. PCR or qPCR assays can then be designed to monitor these markers routinely in production, quality control or environmental samples.
This workflow connects genomic discovery with operational monitoring and helps make strain protection more practical over time.
Biomanda provides bioinformatics services for microbial genomics, comparative genomics and molecular biology. Depending on the project, Biomanda can support genome assembly, annotation, ANI analysis, SNP analysis, pangenome analysis, synteny analysis, marker discovery, primer and probe design and biological interpretation.
The objective is to help companies document proprietary microbial strains, identify genomic markers, monitor stability and build reliable genomic resources for R&D, industrial microbiology and long-term strain management.
Genomics provides powerful tools to help protect proprietary microbial strains. By establishing a genomic identity, identifying strain-specific markers and monitoring stability over time, companies can better manage and document their microbial resources.
For industrial microbiology, this approach supports traceability, quality control, R&D strategy and the long-term value of proprietary strain collections.